Amit Mahajan

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Scott Gettinger, Amit Mahajan et al. · The Lancet Oncology · 2016 · 996 citations · Full text

Medicine, Oncology, Pharmacology +16

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Kurt A. Schalper, Scott Gettinger et al. · The Lancet Oncology · 2020 · 538 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: One-Year Results of the Prospective, Multicenter NAVIGATE Study

Erik Folch, Michael A. Pritchett, Michael Nead et al. · Journal of Thoracic Oncology · 2018 · 407 citations · Full text

Medicine, Clinical Sciences, Radiology +13

Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

Harriet M. Kluger, Veronica Chiang, Amit Mahajan et al. · Journal of Clinical Oncology · 2018 · 277 citations

Medicine, Oncology, Immunotherapy +16

Robotic Bronchoscopy for Peripheral Pulmonary Lesions

Alexander C. Chen, Nicholas J. Pastis, Amit Mahajan et al. · CHEST Journal · 2020 · 244 citations · Full text

Medicine, Clinical Sciences, Radiology +17